Goldman Sachs Sinks Toward Bear-Market Territory

Goldman Sachs is rated Buy after an 18% drawdown pushed its valuation into an attractive range, despite recent technical weakness. The firm reported strong Q2 EPS of $20.98 and $20.3B of revenue, beating estimates, and raised its dividend to $5 per share. Expected recovery in M&A, robust capital-markets issuance, and AI infrastructure investment are cited as key forward earnings drivers.

Analysis

The relevant question is not whether GS is optically cheap after the drawdown, but whether the market is underpricing a durable normalization in investment-banking fee pools. GS has unusually high operating leverage to advisory and underwriting: a sustained recovery in announced M&A and equity issuance can drive earnings revisions materially faster than at more balance-sheet-led peers. The near-term competitive read-through is positive for MS, JPM and EVR, but GS should have the highest beta if large-cap sponsor exits and mega-cap strategic transactions re-open; EVR offers purer advisory exposure but lacks GS's trading and financing earnings floor.

The principal 1-3 month catalyst is a sequence of large announced transactions converting into an improved fee backlog, alongside stronger ECM/DCM activity and management confirmation that compensation growth remains below revenue growth. The risk is that announced deal volume does not translate into completed fees until 2027, while a rates shock, widening credit spreads, or equity volatility can close issuance windows quickly. A soft landing is constructive for GS; a recessionary risk-off event would pressure both investment-banking estimates and the valuation multiple, making the recent technical weakness potentially fundamental rather than flow-driven.

Consensus may be too focused on the cyclical M&A rebound and insufficiently discounts capital-markets share competition and the possibility that AI-related financing remains concentrated in a small group of cash-rich issuers that need little external capital. The more durable upside case requires evidence of improved fee-market share and a better return on capital from the lending/alternatives platform, not simply a quarterly trading or underwriting beat. Falsify a constructive thesis if the next earnings release shows investment-banking fees below peer growth, compensation-to-revenue deterioration, or a meaningful reduction in capital-return capacity.

Key Decisions for Investors

• Initiate a 3-6 month long GS / short JPM pair at approximately equal dollar exposure if GS continues to lag despite stable credit spreads; GS offers greater upside torque to a capital-markets recovery, while JPM hedges broad bank-sector and macro beta. Target 10-15% relative outperformance; exit if GS investment-banking fee growth trails JPM by more than 10 percentage points for a quarter.
• For outright exposure, scale into GS only after confirmation that high-yield spreads remain below 400 bps and the VIX stays below 25; these are practical issuance-window conditions. Use a 7-8% stop from blended entry, with a 12-18% six-month upside target if forward earnings estimates begin rising.
• Prefer EVR as a higher-beta satellite long for a pure advisory recovery, funded against a short in KKR or APO only if private-market exit activity accelerates while asset-management fee-related earnings remain pressured by slower fundraising. This is a watch item until announced M&A volume and completed-fee guidance improve.
• Do not underwrite AI infrastructure as a standalone GS earnings driver without disclosure of financing/advisory wallet share. Monitor large data-center, power, and semiconductor financing mandates; sustained mandate wins would support a 6-18 month multiple expansion case, while generic AI commentary should not change position sizing.